BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 27796514)

  • 21. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.
    Kakeji Y; Yamamoto M; Ito S; Sugiyama M; Egashira A; Saeki H; Morita M; Sakaguchi Y; Toh Y; Maehara Y
    Surg Today; 2012 Apr; 42(4):351-8. PubMed ID: 22245924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.
    Bissolati M; Desio M; Rosa F; Rausei S; Marrelli D; Baiocchi GL; De Manzoni G; Chiari D; Guarneri G; Pacelli F; De Franco L; Molfino S; Cipollari C; Orsenigo E
    Gastric Cancer; 2017 Jan; 20(1):70-82. PubMed ID: 26732876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study.
    Ito H; Inoue H; Odaka N; Satodate H; Suzuki M; Mukai S; Takehara Y; Kida H; Kudo SE
    J Exp Clin Cancer Res; 2013 Jan; 32(1):2. PubMed ID: 23289488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
    Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
    J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter.
    Hoshino I; Gunji H; Ishige F; Iwatate Y; Takiguchi N; Ikeda A; Soda H; Tonooka T; Sato N; Kawahara K; Nabeya Y
    BMC Surg; 2019 Oct; 19(1):152. PubMed ID: 31651313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.
    Dresner SM; Lamb PJ; Bennett MK; Hayes N; Griffin SM
    Surgery; 2001 Jan; 129(1):103-9. PubMed ID: 11150040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jan; 100(2):261-6. PubMed ID: 23180514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Goto H; Tokunaga M; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2013 Oct; 16(4):590-5. PubMed ID: 23179369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma.
    Clark GW; Peters JH; Ireland AP; Ehsan A; Hagen JA; Kiyabu MT; Bremner CG; DeMeester TR
    Ann Thorac Surg; 1994 Sep; 58(3):646-53; discussion 653-4. PubMed ID: 7944684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma.
    Takeda FR; Ramos MFKP; Pereira MA; Sallum RAA; Ribeiro Junior U; Nahas SC; Cecconello I
    Updates Surg; 2022 Dec; 74(6):1871-1879. PubMed ID: 35776245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of lymph nodal metastases in treatment of esophagogastric adenocarcinoma.
    Aikou T; Shimazu H; Takao T; Baba M; Natsugoe S; Simada M
    Lymphology; 1992 Mar; 25(1):31-6. PubMed ID: 1569781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.
    Kurokawa Y; Sasako M; Sano T; Yoshikawa T; Iwasaki Y; Nashimoto A; Ito S; Kurita A; Mizusawa J; Nakamura K;
    Br J Surg; 2015 Mar; 102(4):341-8. PubMed ID: 25605628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate extent of lymphadenectomy for squamous cell carcinoma of the esophagogastric junction.
    Kosugi SI; Ichikawa H; Hanyu T; Ishikawa T; Wakai T
    Int J Surg; 2017 Aug; 44():339-343. PubMed ID: 28709935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T
    Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
    Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
    Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study.
    Han WH; Eom BW; Yoon HM; Reim D; Kim YW; Kim MS; Lee JM; Ryu KW
    BMC Cancer; 2019 Jul; 19(1):719. PubMed ID: 31331305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.